首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌患者综合治疗的疗效及预后分析
引用本文:沈伟娟,凌立君. 乳腺癌患者综合治疗的疗效及预后分析[J]. 中国医药导报, 2011, 8(18): 69-71
作者姓名:沈伟娟  凌立君
作者单位:1. 南京医科大学,江苏南京210029;江苏大学附属武进人民医院乳腺外科,江苏常州213000
2. 南京医科大学第一附属医院乳腺外科,江苏南京,210029
摘    要:目的:探讨可手术的乳腺癌患者综合治疗的疗效、预后及主要影响因素。方法:收集2002年1月~2005年12月236例可手术的乳腺癌患者的临床病理资料,探讨患者的年龄、绝经与否、肿瘤大小、腋窝淋巴结转移数量、TNM分期、激素受体表达情况、化疗、放疗及内分泌治疗的疗效与预后的相关性。结果:236例患者5年生存率为68.6%。肿瘤大小、腋窝淋巴结转移数目及TNM分期与患者生存率呈负相关(P〈0.05)。其中三阴性乳腺癌的生存率较非三阴乳腺癌明显降低(P=0.022)。术后进行化疗、放射治疗或内分泌治疗的患者5年生存率均高于未进行综合治疗的患者(P〈0.05)。年龄、绝经与否、激素受体表达与5年生存率无明显相关(P〉0.05)。结论:肿瘤大小、腋窝淋巴结转移数目、TNM分期、三阴性乳腺癌以及术后是否进行化疗、内分泌治疗、放射治疗均与预后有密切关系。其中肿瘤大小、腋窝淋巴结转移数目和TNM分期为影响乳腺癌患者预后的独立危险因素。

关 键 词:乳腺癌  综合治疗  预后

Clinical analysis of synthetic therapy effect and prognostic factors in breast cancer patients
SHEN Weijuan,LING Lijun. Clinical analysis of synthetic therapy effect and prognostic factors in breast cancer patients[J]. China Medical Herald, 2011, 8(18): 69-71
Authors:SHEN Weijuan  LING Lijun
Affiliation:SHEN Weijuan1,3,LING Lijun2 1.Nanjing Medical University,Nanjing 210029,China,2.Department of Breast Cancer,the First Affiliated Hospital of Nanjing Medical University,3.Department of Breast Cancer,the Affiliated Wujin Hospital of Jiangsu University,Changzhou 213000
Abstract:Objective: To analyze the synthetic therapy effect and prognostic factors in the patients with breast cancer.Methods: From January 2002 to December 2005,the clinical-pathological materials of 236 breast cancer patients who had received synthetic therapy,including surgery,chemotherapy,endocrine therapy and radiotherapy were analyzed.The corre-lation of age,menopausal status,tumor size,axillary lymphnodal status,TNM stage,hormone receptor status,chemotherapy,endocrine therapy and radiotherapy with prognosis o...
Keywords:Breast cancer  Synthetic therapy  Prognosis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号